Mechanism of action and treatment of type I interferon in hepatocellular carcinoma.

Clin Transl Oncol

State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning, 530021, Guangxi, China.

Published: February 2024

Hepatocellular carcinoma (HCC) caused by HBV, HCV infection, and other factors is one of the most common malignancies in the world. Although, percutaneous treatments such as surgery, ethanol injection, radiofrequency ablation, and transcatheter treatments such as arterial chemoembolization are useful for local tumor control, they are not sufficient to improve the prognosis of patients with HCC. External interferon agents that induce interferon-related genes or type I interferon in combination with other drugs can reduce the recurrence rate and improve survival in HCC patients after surgery. Therefore, in this review, we focus on recent advances in the mechanism of action of type I interferons, emerging therapies, and potential therapeutic strategies for the treatment of HCC using IFNs.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-023-03266-7DOI Listing

Publication Analysis

Top Keywords

mechanism action
8
type interferon
8
hepatocellular carcinoma
8
action treatment
4
treatment type
4
interferon hepatocellular
4
carcinoma hepatocellular
4
hcc
4
carcinoma hcc
4
hcc caused
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!